Rational development and evaluation of novel formulations for urinary health

Eur J Obstet Gynecol Reprod Biol. 2022 Feb:269:90-97. doi: 10.1016/j.ejogrb.2021.12.031. Epub 2021 Dec 28.

Abstract

Objective: Urinary tract infections (UTI) among women form a substantial part of medical practice and both patients and medical professionals have an interest in non-antibiotic treatments and preventative measures. This research provides preliminary data on a multi-functional composition, DAPAD, which explored several biologic activities of relevance to UTI.

Study design: This formulation included D-mannose, citric acid, three prebiotic compounds, and extracts of dandelion and astragalus. Studies performed employed 4 bacterial strains that have relevance to UTI including E. coli, Proteus mirabilis, Streptococcus agalactiae and Enterococcus faecalis.

Results: Key findings from in vitro studies included: DAPAD at full- and half-strength inhibited growth of all UTI bacteria. Evidence for D-mannose agglutination of E. coli was demonstrated. D-mannose also showed unexpected effects on bacterial membrane integrity with vital staining and modest growth restriction. We did not demonstrate growth inhibition by dandelion or astragalus extracts but the latter showed diminished cytokine elaboration by bladder epithelial cells.

Conclusion: DAPAD is a multifunctional composition that may warrant further development as a UTI treatment or preventive if supported by clinical evaluation.

Keywords: Citric acid; D-mannose; Prebiotic; Therapy; Urinary tract infections.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Enterococcus faecalis
  • Escherichia coli*
  • Female
  • Humans
  • Proteus mirabilis
  • Urinary Tract Infections* / drug therapy
  • Urinary Tract Infections* / prevention & control

Substances

  • Anti-Bacterial Agents